drugset / Trial / NCT01082874

PeriOperative ISchemic Evaluation-2 Trial

NCT01082874 ↗

RandomizedFactorialQuadruple-blindPrevention

Summary

Major surgeries not involving the heart are common, and major heart problems during or after such surgeries represent a large population health problem. Few treatments to prevent heart problems around the time of surgery have been tested. There is encouraging data suggesting that small doses of Acetyl-Salicylic Acid (ASA) and Clonidine, which are two medications, given individually for a short period before and after major surgeries may prevent major heart problems. The POISE-2 Trial is a large international study to test if ASA and Clonidine can prevent heart attacks and deaths from heart problems around the time of surgery.

Timeline

Start
2010-07
Primary completion
2014-03
Completion
2015-01

Outcome

Missed primary endpoint

paper had no significant effect on the rate of a composite of death or nonfatal myocardial infarction PMID 24679062 ↗

paper hazard ratio in the aspirin group, 0.99; 95% confidence interval [CI], 0.86 to 1.15; P=0.92). PMID 24679062 ↗

paper Clonidine, as compared with placebo, did not reduce the number of primary-outcome events (367 and 339, respectively PMID 24679061 ↗

paper did not reduce the rate of the composite outcome of death or nonfatal myocardial infarction PMID 24679061 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Aspirin Small molecule 100 mg Oral
Subject Clonidine Other / unclassified 0.2 mg Oral